Evaluation of  -adrenergic blocking agents in presence of adrenergic tone.
D000083:Acetanilides / Q000494:pharmacology; D000319:Adrenergic beta-Antagonists / Q000494:pharmacology; D000605:Amino Alcohols / Q000494:pharmacology; D000818:Animals; D001338:Autonomic Fibers, Postganglionic / Q000187:drug effects / Q000502:physiology; D001692:Biological Transport; D001794:Blood Pressure / Q000187:drug effects; D003331:Coronary Vessels / Q000187:drug effects* / Q000502:physiology; D004285:Dogs; D006339:Heart Rate / Q000187:drug effects; D007269:Injections, Intra-Arterial; D009638:Norepinephrine / Q000008:administration & dosage / Q000494:pharmacology / Q000502:physiology; D010096:Oxprenolol / Q000494:pharmacology; D011433:Propranolol / Q000494:pharmacology; D011437:Propylamines / Q000494:pharmacology; D012849:Sinoatrial Node / Q000187:drug effects* / Q000502:physiology; D013015:Sotalol / Q000494:pharmacology; D013233:Stellate Ganglion / Q000502:physiology; D013565:Sympatholytics / Q000494:pharmacology*
D000083:Acetanilides; D000319:Adrenergic beta-Antagonists; D000605:Amino Alcohols; D011437:Propylamines; D013565:Sympatholytics; D010096:Oxprenolol; D011433:Propranolol; D013015:Sotalol; D009638:Norepinephrine